Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
- Zogenix, Inc. (NASDAQ:ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company.
- Fresh Vine Wine, Inc. (NYSE:VINE) rose 36.8% to $7.66 in pre-market trading after jumping around 9% on Tuesday. Fresh Vine Wine recently announced a partnership with CRAVE American Kitchen & Sushi Bar.
- SoFi Technologies, Inc. (NASDAQ:SOFI) rose 16.8% to $14.09 in pre-market trading. The San Francisco-based digital financial services company said Tuesday it had gained approvals from key regulators to become a full-fledged bank.
- Sentage Holdings Inc. (NASDAQ:SNTG) rose 8.3% to $0.85 in pre-market trading following a 7% decline on Tuesday.
- Vinco Ventures, Inc. (NASDAQ:BBIG) shares rose 7.7% to $5.59 in pre-market trading after jumping over 27% on Tuesday.
- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) rose 7.5% to $0.2990 in pre-market trading.
- Lucid Diagnostics Inc. (NASDAQ:LUCD) rose 7% to $4.33 in pre-market trading after declining around 5% on Tuesday.
- Pearson plc (NYSE:PSO) rose 6% to $9.24 in pre-market trading.
- KE Holdings Inc. (NYSE:BEKE) rose 5.5% to $23.25 in pre-market trading after adding 5% on Tuesday.
- Orphazyme A/S (NASDAQ:ORPH) rose 5% to $2.33 in pre-market trading. Orphazyme narrowed its FY21 guidance.
- SuperCom Ltd. (NASDAQ:SPCB) shares rose 4.1% to $0.54 in pre-market trading. SuperCom’s subsidiary, Leaders in Community Alternatives, launched a new $1 million project in Central Coast California.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Cardiff Oncology, Inc. (NASDAQ:CRDF) shares fell 15.2% to $5.21 in pre-market trading after reporting new data from lead clinical program in KRAS-mutated metastatic colorectal cancer showing robust objective response rate and progression free survival.
- Brickell Biotech, Inc. (NASDAQ:BBI) shares fell 9.7% to $0.2979 in pre-market trading. Brickell Biotech shares jumped over 58% on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and $2 price target.
- Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares fell 8.7% to $3.16 in pre-market trading after jumping more than 5% on Tuesday.
- DatChat, Inc. (NASDAQ:DATS) fell 8.1% to $3.06 in pre-market trading. DatChat shares jumped over 38% on Tuesday after the company announced it has initiated the development of a new platform that will leverage DatChat technology to share and protect NFTs, documents, audio and video files and messages.
- Yoshitsu Co., Ltd (NASDAQ:TKLF) fell 7.8% to $29.50 in pre-market trading.
- Venus Concept Inc. (NASDAQ:VERO) fell 6.4% to $1.62 in pre-market trading. Venus Concept announced it received 510(k) clearance from the FDA to market the Venus BlissMAX device in the United States.
- OneSmart International Education Group Limited (NYSE:ONE) shares fell 6.2% to $0.1450 in pre-market trading after tumbling 17% on Tuesday.
- Sony Group Corporation (NYSE:SONY) fell 5.1% to $109.90 in pre-market trading following news of Microsoft buying Activision Blizzard.
- Phunware, Inc. (NASDAQ:PHUN) shares fell 4% to $3.12 in pre-market trading after jumping over 12% on Tuesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.